SBC Medical Q4 revenue down 29% to $44M; FY 2024 net income up 18% to $47M

SBC Medical Group Holdings Inc

Q4 2024 revenue $44M (down 29% YoY); net income $7M (down 54% YoY); EPS $0.06 (down 58%).
Full-year 2024 revenue $205M (up 6% YoY); net income $47M (up 18% YoY); EPS $0.48 (up 14%).
Q4 EBITDA $21M (down 22% YoY) with margin 47%; full-year EBITDA $89M (up 8% YoY) with margin 43%.
Partner clinics grew by 43 to 251 as of Dec 31, 2024, expanding the clinic network.
Income from operations fell 80% in Q4 to $5M but was nearly flat for the full year at $70M.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.